Connective tissue and genetics in the pathogenesis of rectal prolapse: A scoping review
Abstract
Aim: Rectal prolapse can occur in individuals who lack the established risk factors (constipation, obstetric trauma and advanced age). A recognised association with hereditary connective tissue diseases may indicate a role for variants in connective tissue-related genes in the pathogenesis of the disease. This scoping review evaluates the evidence supporting this.
Methods: A scoping review was performed using a systematic search of Medline, Embase, CINAHL and The Cochrane Library in March 2026. Studies describing any of the following in the context of rectal prolapse were included: epidemiology in individuals with hereditary connective tissue disease, tissue morphology, disease heritability or genetic testing of affected individuals. Study design and key findings were collated and summarised.
Results: Sixty of 4442 screened sources were eligible for inclusion. Rectal prolapse is common in Ehlers-Danlos Syndrome (3.2%-18%), Marfan's syndrome (6%) and joint hypermobility (4.9%-11%). Hypermobility is associated with post-operative recurrence and younger age of onset. Abnormal pelvic floor collagen and elastin organisation, reduced myofibroblast density and increased dermal elastin density were key examples of abnormal tissue morphology in individuals with rectal prolapse. Patterns of heritability have not been adequately evaluated, but novel variants in connective tissue-related genes (e.g. EFEMP1, COLGALT2, FBLN5 and TNXB) are reported in individuals with rectal prolapse.…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.